[Doctor's Explanation] How High Is the NIPT (Non-Invasive Prenatal Testing) Positive Rate? — Probabilities by Condition and How to Correctly Interpret Results —

Rewritten on: April 6, 2026

To correctly understand the NIPT positive rate, this article explains in detail — from a specialist physician's perspective — the difference between detection sensitivity and positive predictive value (PPV), the differences in accuracy by condition and by age, the mechanism behind false positives, and the concrete steps to take if a positive result occurs.

"If I get NIPT, what's the probability of testing positive?"
We often receive this kind of question from expectant mothers considering prenatal testing. NIPT (Non-Invasive Prenatal Testing) is a test that evaluates the risk of chromosomal abnormalities in the fetus by analyzing fetal-derived cell-free DNA (cfDNA) contained in the mother's blood. It is known as a highly accurate test, but "positive" does not mean "the condition is confirmed."

NIPT is ultimately a screening test, and even if a positive result appears, it only indicates "elevated risk." A definitive diagnosis requires an invasive test such as amniocentesis or chorionic villus sampling. Fully understanding this point leads to a calm, rational assessment of test results.

In this article, we explain from a specialist physician's perspective the actual positive rates for each condition, the true meaning behind the numbers in test results, and how to think about a positive result. By gaining accurate knowledge about NIPT's positive rate, you can consider your next steps calmly, without being overwhelmed by anxiety. Note that in Japan, the Prenatal Testing Accreditation System Steering Committee was established in 2022, and efforts are underway to establish an appropriate framework for administering NIPT. Being aware of these institutional developments can also help you feel more at ease when undergoing testing. (1)

Two Key Concepts for Understanding NIPT's "Positive Rate"

To correctly understand NIPT's positive rate, it is essential to distinguish between the following two perspectives. These two concepts are fundamental to medical testing in general, but they have a particularly large impact on how NIPT results should be interpreted. Understanding the basics of medical statistics allows you to make appropriate judgments without feeling excessive anxiety about test results.

• Detection sensitivity (Sensitivity): Among babies who actually have the condition, the proportion for which the test result correctly comes back "positive." The higher the sensitivity, the lower the probability of missing the condition. For trisomy 21, NIPT's primary target, sensitivity is extremely high — over 99%. However, note that high sensitivity does not mean every positive result is correct.
• Positive Predictive Value (PPV): Among people who tested "positive," the actual probability that the baby has the condition. PPV is heavily influenced by the prevalence of the condition (how frequently it occurs). This is a statistical characteristic in which, for conditions with low prevalence, PPV decreases even when sensitivity is high.

Confusing these two concepts can lead to major misunderstandings about what a result means. For example, hearing that NIPT's detection sensitivity is 99% might make you think, "If it's positive, there's a 99% chance the baby has an abnormality," but that is not correct. The actual "Positive Predictive Value (PPV)" varies greatly depending on the mother's age and the condition being tested. When a condition's incidence is low, PPV can drop substantially even if sensitivity is very high — this is a statistical property. This phenomenon is based on the fundamental probability principle known as Bayes' theorem, and it is a characteristic common to all screening tests, not just NIPT. (2)

It should also be noted that NIPT's specificity (the proportion of babies without the condition who are correctly judged "negative") is reported to be over 99.9%. Thanks to this extremely high specificity, the rate of false positives is kept low, but for conditions with low prevalence, a certain number of false positives are still unavoidable. It is important to understand both the high accuracy of the test and the points to note when interpreting the results. (3)

NIPT Positive Rate and Accuracy Differences by Condition

There are several types of conditions that can be tested with NIPT, each with different levels of detection sensitivity and positive predictive value. Let's take a detailed look at the approximate positive rates (detection sensitivity and PPV) for each condition. NIPT's testing targets are broadly divided into three categories: autosomal trisomies (trisomy 21, 18, and 13), sex chromosome abnormalities, and microdeletion syndromes. Accurately understanding the accuracy characteristics of each is essential for properly interpreting test results.

1. The Most Commonly Tested Conditions: "Trisomy 21, 18, and 13"

The conditions most frequently tested with NIPT are trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). These three autosomal trisomies are NIPT's primary testing targets, and the most research data has accumulated for them. Large-scale clinical trials have been conducted around the world, and there is a wealth of evidence regarding the accuracy of these tests.

*Figures are approximate values based on general reports.

While NIPT's detection sensitivity for these conditions is very high (97–99%+), the positive predictive value varies depending on how frequently the condition occurs. For trisomy 18 and trisomy 13, which occur less frequently, PPV tends to be relatively lower than for trisomy 21 (meaning more false positives).

Trisomy 21 (Down syndrome) is the most frequently occurring chromosomal abnormality at birth, occurring in approximately 1 in 700–800 births. For this reason, NIPT shows a relatively high PPV of 82% for this condition. Trisomy 18 (Edwards syndrome), on the other hand, occurs in about 1 in 3,500–8,500 births, and trisomy 13 (Patau syndrome) in about 1 in 10,000–20,000 births — both relatively low frequencies — resulting in correspondingly lower PPV values.

Note that trisomy 18 and trisomy 13 are often accompanied by severe complications, and their postnatal prognosis differs greatly from that of trisomy 21. For trisomy 18, the one-year survival rate is estimated at around 5–10%, and for trisomy 13 it is even lower. Therefore, when these conditions are suspected, comprehensive counseling that includes preparation for postnatal medical care is needed. (2)(4)

2. How the "True Probability of a Positive Result" Changes with Age

An important additional point is that the positive predictive value (PPV) is heavily dependent on prior probability factors such as maternal age. For example, because the incidence of trisomy 21 increases with maternal age, PPV tends to be lower for younger pregnant women who test positive and higher for older pregnant women. This is a statistical necessity based on Bayes' theorem, and it does not mean that the accuracy of the test itself changes with age.

Specifically, for a 25-year-old pregnant woman, the prevalence of trisomy 21 is low, at approximately 1 in 1,300, so even a positive NIPT result may only correspond to a PPV of around 50%. For women 40 and older, on the other hand, prevalence rises to approximately 1 in 100, so PPV can reach 90% or higher. Even with the same test performance, the interpretation of results changes depending on the woman's background — this is an important point to note.

Please refer to the following age-related guidelines to understand how risk differs by age.

• Early 20s: The prevalence of trisomy 21 is approximately 1 in 1,500 to 1 in 1,300. Even with a positive NIPT result, PPV may be around 40–50%.
• Early 30s: Prevalence rises to approximately 1 in 900 to 1 in 600. PPV tends to improve to the 60–70% range.
• 35 and older: Prevalence is approximately 1 in 350 to 1 in 250. PPV reaches around 80%, increasing test reliability.
• 40 and older: Prevalence rises to approximately 1 in 100 or higher. PPV reaches 90% or above, giving very high confidence in a positive result.

ACOG (the American College of Obstetricians and Gynecologists) guidelines also emphasize the importance of taking maternal age and other risk factors into account when interpreting NIPT results. In particular, when a younger pregnant woman tests positive on NIPT, the likelihood of a false positive is higher, making confirmation via diagnostic testing all the more important. In its 2020 Practice Bulletin, ACOG stated that while all pregnant women should be offered prenatal screening options including NIPT, interpreting positive results requires individualized risk assessment. (5)

3. "Sex Chromosome Abnormalities" — Surprisingly Common but Difficult to Interpret

Sex chromosome abnormalities (such as Turner syndrome and Klinefelter syndrome) have a detection sensitivity with NIPT roughly comparable to that of autosomal trisomies (approximately 100%). However, the positive predictive value varies considerably by condition.

• Sex chromosome trisomies (Klinefelter syndrome: 47,XXY, etc.): PPV is relatively high, at 57.5–100%. Klinefelter syndrome occurs in approximately 1 in 500–1,000 people, making it a relatively common sex chromosome abnormality.
• Turner syndrome (45,X): PPV is 14.5–32%, with a higher rate of false positives. This is largely due to the effects of confined placental mosaicism (CPM).
• Triple X syndrome (47,XXX) and XYY syndrome (47,XYY): PPV varies by condition, but is generally reported in the range of 50–80%.

The higher rate of false positives seen in conditions such as Turner syndrome is believed to be influenced by factors such as "confined placental mosaicism" (CPM), in which the abnormality is present only in placental cells, as well as changes in the mother's own cells. NIPT analyzes fetal-derived cfDNA (cell-free DNA) floating in maternal blood, but most of this cfDNA actually originates from placental trophoblast cells. As a result, when a chromosomal abnormality is present only in the placenta (CPM), the test result can come back positive even though the fetus itself is normal.

Loss of the X chromosome associated with maternal aging (age-related mosaicism) is also one of the factors contributing to false positives for Turner syndrome. As women age, some blood cells may lose an X chromosome, which can affect NIPT analysis results.

Furthermore, because sex chromosome abnormalities present with a wide range of symptoms and some cases are not noticed until after birth, there are ethical and psychological difficulties in deciding "how to respond after learning of a positive result." In the case of Klinefelter syndrome (47,XXY), many individuals live ordinary lives and are not diagnosed until adulthood. As such, how to respond to a positive NIPT result for a sex chromosome abnormality is an issue deeply tied to the values of the individual and their partner. It is essential to receive thorough information during genetic counseling about the clinical presentation and prognosis of each condition. (3)

4. "Microdeletion Syndromes" Requiring Careful Judgment

In recent years, an increasing number of facilities offer testing for microdeletion syndromes (conditions in which a very small portion of a chromosome is missing) as an additional option. A representative example is 22q11.2 deletion syndrome (also known as DiGeorge syndrome), but because these conditions have an extremely low prevalence (they are rare), caution is needed.

Test accuracy for microdeletion syndromes: detection sensitivity approximately 20–100%, positive predictive value approximately 3–100% — an extremely wide range.

For conditions with low prevalence, even if the test itself has high sensitivity, the positive predictive value can statistically become extremely low. In other words, NIPT for microdeletion syndromes is an area where "positive" cannot be equated with "confirmed", and it requires even more careful interpretation than autosomal trisomies. Because microdeletion regions are extremely small, the analysis is technically difficult, which also increases the risk of false positives.

22q11.2 deletion syndrome occurs at a frequency of about 1 in 4,000 births, making it relatively common among microdeletion syndromes, but NIPT's PPV for it varies greatly depending on the facility and analytical method used. One large-scale study reported that NIPT's PPV for 22q11.2 deletion was as low as only 5–20%. As this shows, screening for microdeletion syndromes is still a technically developing field, and when a positive result occurs, it is strongly recommended that it be confirmed with a precise test such as chromosomal microarray analysis or FISH.

If you wish to be tested for microdeletion syndromes, we strongly recommend fully understanding the limitations of the test and consulting with a genetic counselor or specialist physician. (6)

The Mechanism Behind NIPT "False Positives"

Understanding why NIPT false positives occur will help you respond calmly if you receive a positive result. A false positive refers to a case in which the test result comes back "positive (high risk)" even though the baby itself has no chromosomal abnormality. The main causes of false positives include the following.

1. Confined Placental Mosaicism (CPM): A condition in which a chromosomal abnormality is present only in part of the placenta while the fetus itself is normal. Because most of the cfDNA analyzed by NIPT originates from the placenta, this is the most common cause of false positives. CPM is thought to occur in about 1–2% of all pregnancies, and it is known to have a particularly large impact on screening for trisomy 13 and sex chromosome abnormalities.
2. Maternal chromosomal abnormalities: When the mother herself has a mosaic-type chromosomal abnormality, or in cases of age-related loss of the X chromosome in somatic cells (age-related mosaicism), test results can be affected. This is particularly associated with false positives for sex chromosome abnormalities. Older pregnant women are more susceptible to the effects of age-related mosaicism.
3. Vanishing twin: When one twin in an early twin pregnancy is lost, the cfDNA from the lost twin can remain and cause a false positive. Some reports suggest that vanishing twin occurs in approximately 20–30% of all pregnancies, and the frequency is said to be particularly high in pregnancies conceived through in vitro fertilization (IVF). (7)
4. Maternal tumors: Very rarely, if the mother has a tumor (benign or malignant), abnormal cfDNA originating from the tumor can interfere with test results. In fact, cases have been reported in the literature in which an abnormal NIPT result led to the discovery of a malignant tumor in the mother. (8)
5. Technical factors: When the fetal fraction of cfDNA is low, or due to limitations in the analysis algorithm, accurate determination can become difficult. If the fetal fraction is below 4%, test reliability decreases, and retesting or another testing method should be considered.

Given these causes, it becomes clearer why it is important to understand that a positive NIPT result is "not confirmed" and to consider diagnostic testing as the next step. The mechanisms behind false positives are complex, but in every case, an accurate diagnosis can be obtained through diagnostic testing (amniocentesis or chorionic villus sampling).

NIPT "False Negatives" Also Require Attention

While it is important to understand false positives in NIPT, you should also be aware of the possibility of false negatives (cases where the condition is actually present but the result comes back "negative"). NIPT's negative predictive value (NPV) is extremely high, over 99.9%, so when a negative result is obtained, the probability that the baby is healthy is very high.

However, it is also true that this is not 100%. Possible causes of false negatives include the following. (5)

• Low fetal fraction: If the proportion of fetal-derived cfDNA in maternal blood (fetal fraction) is low, the signal for a chromosomal abnormality may not be sufficiently detected. Fetal fraction is affected by factors such as gestational age and maternal BMI.
• Mosaic-type chromosomal abnormalities: In "mosaic" cases where the abnormality is present in only some of the fetus's cells, the abnormal signal may be weak and difficult to detect.
• Technical limitations: Particularly for microdeletion syndromes or rare chromosomal abnormalities, limitations in analytical technology can result in false negatives.

Although the risk of a false negative is very low, it is important to understand that a negative NIPT result does not rule out all chromosomal abnormalities or genetic conditions. NIPT can only test for specific chromosomal abnormalities and does not cover every genetic condition. It is recommended that you continue to receive regular prenatal checkups and ultrasound examinations.

What Matters More Than the "Positive Rate" Is How You Approach the Results

Summarizing what has been covered so far, the positive predictive value (PPV) tends to decline progressively as the range of tested conditions expands. While PPV for autosomal trisomies is relatively high, it becomes more variable for sex chromosome abnormalities, and even more unstable for microdeletion syndromes.

The most important thing to keep in mind is the fact that "NIPT is not a definitive diagnosis — it is ultimately a screening test." Even if the result comes back "positive (high risk)," a diagnosis is only confirmed after undergoing a diagnostic test such as amniocentesis.

The greatest advantage of NIPT is that, because it is non-invasive (requiring only a blood sample from the mother), it carries no risk of miscarriage. On the other hand, diagnostic tests such as amniocentesis and chorionic villus sampling carry a small but real risk of miscarriage (approximately 0.1–0.3%). NIPT is positioned as a "first-stage screening" test to help determine whether an invasive test should be pursued.

Rather than reacting emotionally to numbers alone, it is far more important to correctly understand what the results actually mean. Even a negative (low-risk) NIPT result does not guarantee 100% that no condition is present (a small possibility of a false negative still exists). However, given NIPT's high negative predictive value (NPV: over 99.9%), a negative result indicates with very high confidence that the baby is healthy.

Whether to undergo NIPT, and which test items to select, is ultimately a decision left to the pregnant woman and her partner. Receiving thorough information and genetic counseling before testing will help you make the best choice for your own circumstances. In Japan as well, an appropriate testing framework is being established under the Prenatal Testing Accreditation System, and accredited facilities are required to provide genetic counseling both before and after testing. (1)(5)

Concrete Steps to Take After a Positive NIPT Result

If you do receive a positive NIPT result, it is recommended that you respond according to the following steps. Feeling anxious or unsettled is natural, but carefully working through each step will lead to the best possible decision.

1. First, stay calm and take it in: A positive NIPT result is only a screening result — it is not a definitive diagnosis. Remember that, particularly for trisomy 18, trisomy 13, sex chromosome abnormalities, and microdeletion syndromes, there is a certain likelihood of a false positive. A positive result does not mean the baby has the condition.
2. Undergo genetic counseling: Receive a detailed explanation from a genetic counselor or specialist physician about what the test result means and what options are available going forward. You can learn how the specific numbers apply to your individual case, taking into account your age and risk factors. Genetic counseling can also provide information about the clinical presentation, prognosis, and available support systems for the condition in question.
3. Consider diagnostic testing: Consider whether to undergo amniocentesis or chorionic villus sampling. A diagnostic test can determine whether the NIPT result was a true positive or a false positive. Because diagnostic tests carry a small risk, it is important to fully understand the benefits and drawbacks before deciding. Amniocentesis is typically performed around 15–20 weeks of pregnancy and provides a definitive diagnosis through karyotype analysis of the chromosomes. (5)
4. Talk with your partner and family: Discuss the test results and future plans thoroughly with your partner and family. Receiving emotional support is extremely important for easing psychological burden. Rather than carrying the weight alone, it is important to share your feelings with someone you trust.
5. Make use of professional support: Consider using a psychological counselor or support group if needed. Sharing the anxiety or stress related to NIPT results with a professional can help you make calmer decisions. In many regions, peer support groups and consultation services related to prenatal diagnosis are available.

Summary: Talk with Your Partner Before Getting Tested

Before undergoing NIPT, discussing with your partner in advance "what we would do if the result comes back positive" is a very effective form of emotional preparation.

As explained in this article, NIPT's positive rate varies greatly depending on the type of condition and the age of the pregnant woman. The PPV for trisomy 21 is relatively high, at approximately 82%, but it is 37% for trisomy 18, 14.5–32% for Turner syndrome among sex chromosome abnormalities, and 3–100% for microdeletion syndromes — PPV becomes increasingly unstable as the range of tested conditions expands.

Let's review the key points to keep in mind before testing.

• NIPT is a screening test and not a definitive diagnosis
• Even with high detection sensitivity, the positive predictive value (PPV) varies greatly by condition and age
• Even with a positive result, there is always a possibility of a false positive
• A definitive diagnosis requires amniocentesis or chorionic villus sampling
• A negative result is not a 100% guarantee, but the negative predictive value is extremely high, over 99.9%
• Interpreting test results requires genetic counseling

Please always keep in mind that NIPT is ultimately a screening test and not a definitive diagnosis. Even if a positive result occurs, an accurate diagnosis can be reached through genetic counseling and diagnostic testing.

Once you fully understand the meaning and limitations of the numbers, please approach testing with peace of mind. At the seeDNA Genetic Medicine Research Institute, our specialist staff are happy to carefully address any concerns or questions you may have before or after testing. If you have any questions about the test or would like guidance interpreting your results, please feel free to contact us.

\Find out your risk of Down syndrome or sex chromosome conditions during pregnancy/

Frequently Asked Questions

Q1. If NIPT comes back positive for trisomy 21, what's the actual probability that the baby has Down syndrome?

A. The positive predictive value (PPV) for trisomy 21 (Down syndrome) is reported to be approximately 82%. NIPT is a highly sensitive test (99.3%), but because it is not a definitive diagnosis, confirmation via a diagnostic test such as amniocentesis is required for a final determination. PPV also varies with the mother's age, remaining around 50% for women in their mid-20s, while reaching 90% or higher for women 40 and older. (2)

Q2. What is the positive predictive value for trisomy 18 or trisomy 13?

A. The positive predictive value (PPV) is reported to be 37% for trisomy 18 and 49% for trisomy 13, both lower than for trisomy 21. This is because these conditions occur less frequently, meaning that a positive result is more likely to be a false positive than with trisomy 21. Confirmation through diagnostic testing is especially important for these conditions. (2)

Q3. How much does NIPT's positive predictive value change with age?

A. The positive predictive value (PPV) is heavily dependent on maternal age. For trisomy 21, for example, PPV may be only around 50% for younger pregnant women in their mid-20s, while it can reach 90% or higher for women 40 and older. This is because the prevalence (prior probability) of trisomy 21 rises with age. Because the same test result can be interpreted differently depending on age, it is important to receive an individualized explanation through genetic counseling. (5)

Q4. What should I be aware of regarding NIPT testing for microdeletion syndromes?

A. Because microdeletion syndromes have an extremely low prevalence, the positive predictive value (PPV) ranges very widely — approximately 3–100% — making it statistically unstable. In particular, some reports indicate that the PPV for 22q11.2 deletion syndrome is as low as 5–20%, meaning "positive" cannot be equated with "confirmed." More careful interpretation is required than for autosomal trisomies, and if you wish to undergo this testing, we recommend consulting thoroughly with a genetic counselor or specialist physician beforehand. (6)

Q5. What should I do next if NIPT comes back positive?

A. If NIPT comes back positive, it is recommended that you first undergo genetic counseling. From there, you can consider whether to undergo a diagnostic test such as amniocentesis or chorionic villus sampling. Because a diagnosis is only confirmed through diagnostic testing, it is important not to rush to conclusions based solely on a positive NIPT result. Talk thoroughly with your partner and family, and make use of professional support. (5)

Q6. What causes false positives in NIPT?

A. The main causes of false positives in NIPT include confined placental mosaicism (CPM), chromosomal changes in the mother herself (such as age-related mosaicism), vanishing twin, and, rarely, maternal tumors. Because most of the cfDNA analyzed by NIPT originates from the placenta, false positives are more likely to occur when a chromosomal abnormality is present only in the placenta. Test reliability can also decrease when the fetal fraction is low.

Q7. Can I fully trust a negative NIPT result?

A. Because NIPT's negative predictive value (NPV) is extremely high, over 99.9%, the reliability of a negative result is very high. However, it is also true that a very small possibility of a false negative exists. In addition, NIPT can only test for specific chromosomal abnormalities and does not cover every genetic condition. It is recommended that you continue to receive regular prenatal checkups and ultrasound examinations. (3)

[References]

(1) J Clin Med, June 2022
(2) Prenatal Testing Accreditation System Steering Committee, March 2021
(3) Medical Doc, March 2026
(4) BMJ Open, January 2016
(5) Diagn Cytopathol, February 2016
(6) Pregnancy & Childbirth Helpful Column, December 2025
(7) The American College of Obstetricians and Gynecologists, February 2020
(8) Int J Cancer, July 2015